nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—obesity	0.543	1	CiPCiCtD
Gabapentin—bipolar disorder—Topiramate—obesity	0.284	1	CpDpCtD
Gabapentin—CACNA1B—respiratory system—obesity	0.00172	0.0873	CbGeAlD
Gabapentin—CACNA2D1—hindbrain—obesity	0.00146	0.0741	CbGeAlD
Gabapentin—BCAT1—islet of Langerhans—obesity	0.00143	0.0727	CbGeAlD
Gabapentin—BCAT1—respiratory system—obesity	0.00135	0.0686	CbGeAlD
Gabapentin—CACNA2D2—islet of Langerhans—obesity	0.00131	0.0667	CbGeAlD
Gabapentin—CACNA2D2—respiratory system—obesity	0.00124	0.0629	CbGeAlD
Gabapentin—CACNA1B—pituitary gland—obesity	0.00116	0.0592	CbGeAlD
Gabapentin—BCAT1—pituitary gland—obesity	0.000915	0.0466	CbGeAlD
Gabapentin—BCAT1—adipose tissue—obesity	0.000911	0.0464	CbGeAlD
Gabapentin—CACNA2D2—pituitary gland—obesity	0.000839	0.0427	CbGeAlD
Gabapentin—BCAT1—adrenal gland—obesity	0.000817	0.0416	CbGeAlD
Gabapentin—CACNA2D2—adrenal gland—obesity	0.000749	0.0381	CbGeAlD
Gabapentin—BCAT1—endocrine gland—obesity	0.000709	0.0361	CbGeAlD
Gabapentin—CACNA2D1—cardiovascular system—obesity	0.000681	0.0347	CbGeAlD
Gabapentin—ADORA1—cardiovascular system—obesity	0.000657	0.0335	CbGeAlD
Gabapentin—CACNA2D2—endocrine gland—obesity	0.00065	0.0331	CbGeAlD
Gabapentin—CACNA2D1—adipose tissue—obesity	0.000601	0.0306	CbGeAlD
Gabapentin—ADORA1—adipose tissue—obesity	0.00058	0.0295	CbGeAlD
Gabapentin—CACNA2D1—adrenal gland—obesity	0.000539	0.0274	CbGeAlD
Gabapentin—CACNA2D1—endocrine gland—obesity	0.000467	0.0238	CbGeAlD
Gabapentin—ADORA1—endocrine gland—obesity	0.000451	0.0229	CbGeAlD
Gabapentin—CACNA2D1—liver—obesity	0.000421	0.0214	CbGeAlD
Gabapentin—Anxiety—Sibutramine—obesity	4.04e-05	0.000366	CcSEcCtD
Gabapentin—Nervousness—Bupropion—obesity	4.03e-05	0.000365	CcSEcCtD
Gabapentin—Anaphylactic shock—Orlistat—obesity	4.01e-05	0.000364	CcSEcCtD
Gabapentin—Oedema—Orlistat—obesity	4.01e-05	0.000364	CcSEcCtD
Gabapentin—Back pain—Bupropion—obesity	4.01e-05	0.000364	CcSEcCtD
Gabapentin—Discomfort—Sibutramine—obesity	4e-05	0.000363	CcSEcCtD
Gabapentin—Muscle spasms—Bupropion—obesity	3.99e-05	0.000361	CcSEcCtD
Gabapentin—Infection—Orlistat—obesity	3.99e-05	0.000361	CcSEcCtD
Gabapentin—Breast disorder—Topiramate—obesity	3.97e-05	0.000359	CcSEcCtD
Gabapentin—Dry mouth—Sibutramine—obesity	3.96e-05	0.000359	CcSEcCtD
Gabapentin—Nervous system disorder—Orlistat—obesity	3.94e-05	0.000357	CcSEcCtD
Gabapentin—Nasopharyngitis—Topiramate—obesity	3.93e-05	0.000356	CcSEcCtD
Gabapentin—Confusional state—Sibutramine—obesity	3.92e-05	0.000355	CcSEcCtD
Gabapentin—Vision blurred—Bupropion—obesity	3.91e-05	0.000354	CcSEcCtD
Gabapentin—Skin disorder—Orlistat—obesity	3.9e-05	0.000353	CcSEcCtD
Gabapentin—Tremor—Bupropion—obesity	3.89e-05	0.000352	CcSEcCtD
Gabapentin—Gastritis—Topiramate—obesity	3.89e-05	0.000352	CcSEcCtD
Gabapentin—Oedema—Sibutramine—obesity	3.89e-05	0.000352	CcSEcCtD
Gabapentin—Anaphylactic shock—Sibutramine—obesity	3.89e-05	0.000352	CcSEcCtD
Gabapentin—Hyperhidrosis—Orlistat—obesity	3.88e-05	0.000351	CcSEcCtD
Gabapentin—Muscular weakness—Topiramate—obesity	3.87e-05	0.000351	CcSEcCtD
Gabapentin—Infection—Sibutramine—obesity	3.86e-05	0.00035	CcSEcCtD
Gabapentin—Ill-defined disorder—Bupropion—obesity	3.85e-05	0.000349	CcSEcCtD
Gabapentin—Anaemia—Bupropion—obesity	3.84e-05	0.000347	CcSEcCtD
Gabapentin—Shock—Sibutramine—obesity	3.82e-05	0.000346	CcSEcCtD
Gabapentin—Agitation—Bupropion—obesity	3.81e-05	0.000345	CcSEcCtD
Gabapentin—Thrombocytopenia—Sibutramine—obesity	3.8e-05	0.000345	CcSEcCtD
Gabapentin—Dysphagia—Topiramate—obesity	3.8e-05	0.000344	CcSEcCtD
Gabapentin—Asthma—Topiramate—obesity	3.8e-05	0.000344	CcSEcCtD
Gabapentin—Angioedema—Bupropion—obesity	3.79e-05	0.000343	CcSEcCtD
Gabapentin—Tachycardia—Sibutramine—obesity	3.79e-05	0.000343	CcSEcCtD
Gabapentin—Skin disorder—Sibutramine—obesity	3.77e-05	0.000342	CcSEcCtD
Gabapentin—Eosinophilia—Topiramate—obesity	3.76e-05	0.00034	CcSEcCtD
Gabapentin—Hyperhidrosis—Sibutramine—obesity	3.76e-05	0.00034	CcSEcCtD
Gabapentin—Malaise—Bupropion—obesity	3.74e-05	0.000339	CcSEcCtD
Gabapentin—Vertigo—Bupropion—obesity	3.73e-05	0.000338	CcSEcCtD
Gabapentin—Syncope—Bupropion—obesity	3.72e-05	0.000337	CcSEcCtD
Gabapentin—Pancreatitis—Topiramate—obesity	3.72e-05	0.000337	CcSEcCtD
Gabapentin—Leukopenia—Bupropion—obesity	3.72e-05	0.000336	CcSEcCtD
Gabapentin—Anorexia—Sibutramine—obesity	3.7e-05	0.000335	CcSEcCtD
Gabapentin—Sweating increased—Topiramate—obesity	3.7e-05	0.000335	CcSEcCtD
Gabapentin—Angina pectoris—Topiramate—obesity	3.7e-05	0.000335	CcSEcCtD
Gabapentin—Palpitations—Bupropion—obesity	3.67e-05	0.000332	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Orlistat—obesity	3.66e-05	0.000331	CcSEcCtD
Gabapentin—Bronchitis—Topiramate—obesity	3.65e-05	0.000331	CcSEcCtD
Gabapentin—Loss of consciousness—Bupropion—obesity	3.65e-05	0.00033	CcSEcCtD
Gabapentin—Insomnia—Orlistat—obesity	3.63e-05	0.000329	CcSEcCtD
Gabapentin—Hypotension—Sibutramine—obesity	3.63e-05	0.000329	CcSEcCtD
Gabapentin—Cough—Bupropion—obesity	3.62e-05	0.000328	CcSEcCtD
Gabapentin—Paraesthesia—Orlistat—obesity	3.61e-05	0.000326	CcSEcCtD
Gabapentin—Convulsion—Bupropion—obesity	3.6e-05	0.000326	CcSEcCtD
Gabapentin—Hypertension—Bupropion—obesity	3.58e-05	0.000324	CcSEcCtD
Gabapentin—Dysuria—Topiramate—obesity	3.55e-05	0.000321	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Sibutramine—obesity	3.54e-05	0.000321	CcSEcCtD
Gabapentin—Dyspepsia—Orlistat—obesity	3.53e-05	0.00032	CcSEcCtD
Gabapentin—Chest pain—Bupropion—obesity	3.53e-05	0.00032	CcSEcCtD
Gabapentin—Arthralgia—Bupropion—obesity	3.53e-05	0.00032	CcSEcCtD
Gabapentin—Myalgia—Bupropion—obesity	3.53e-05	0.00032	CcSEcCtD
Gabapentin—Upper respiratory tract infection—Topiramate—obesity	3.53e-05	0.000319	CcSEcCtD
Gabapentin—Anxiety—Bupropion—obesity	3.52e-05	0.000319	CcSEcCtD
Gabapentin—Insomnia—Sibutramine—obesity	3.51e-05	0.000318	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	3.51e-05	0.000318	CcSEcCtD
Gabapentin—Pollakiuria—Topiramate—obesity	3.51e-05	0.000317	CcSEcCtD
Gabapentin—Erectile dysfunction—Topiramate—obesity	3.5e-05	0.000317	CcSEcCtD
Gabapentin—Discomfort—Bupropion—obesity	3.49e-05	0.000316	CcSEcCtD
Gabapentin—Decreased appetite—Orlistat—obesity	3.49e-05	0.000316	CcSEcCtD
Gabapentin—Paraesthesia—Sibutramine—obesity	3.49e-05	0.000316	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Orlistat—obesity	3.47e-05	0.000314	CcSEcCtD
Gabapentin—Dyspnoea—Sibutramine—obesity	3.46e-05	0.000314	CcSEcCtD
Gabapentin—Photosensitivity reaction—Topiramate—obesity	3.46e-05	0.000314	CcSEcCtD
Gabapentin—Fatigue—Orlistat—obesity	3.46e-05	0.000313	CcSEcCtD
Gabapentin—Dry mouth—Bupropion—obesity	3.46e-05	0.000313	CcSEcCtD
Gabapentin—Somnolence—Sibutramine—obesity	3.45e-05	0.000313	CcSEcCtD
Gabapentin—Weight increased—Topiramate—obesity	3.45e-05	0.000313	CcSEcCtD
Gabapentin—Weight decreased—Topiramate—obesity	3.43e-05	0.000311	CcSEcCtD
Gabapentin—Pain—Orlistat—obesity	3.43e-05	0.000311	CcSEcCtD
Gabapentin—Hyperglycaemia—Topiramate—obesity	3.42e-05	0.00031	CcSEcCtD
Gabapentin—Dyspepsia—Sibutramine—obesity	3.42e-05	0.00031	CcSEcCtD
Gabapentin—Confusional state—Bupropion—obesity	3.42e-05	0.000309	CcSEcCtD
Gabapentin—Pneumonia—Topiramate—obesity	3.4e-05	0.000308	CcSEcCtD
Gabapentin—Anaphylactic shock—Bupropion—obesity	3.39e-05	0.000307	CcSEcCtD
Gabapentin—Oedema—Bupropion—obesity	3.39e-05	0.000307	CcSEcCtD
Gabapentin—Infestation—Topiramate—obesity	3.38e-05	0.000306	CcSEcCtD
Gabapentin—Infestation NOS—Topiramate—obesity	3.38e-05	0.000306	CcSEcCtD
Gabapentin—Decreased appetite—Sibutramine—obesity	3.38e-05	0.000306	CcSEcCtD
Gabapentin—Depression—Topiramate—obesity	3.37e-05	0.000306	CcSEcCtD
Gabapentin—Infection—Bupropion—obesity	3.37e-05	0.000305	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Topiramate—obesity	3.35e-05	0.000304	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Sibutramine—obesity	3.35e-05	0.000304	CcSEcCtD
Gabapentin—Shock—Bupropion—obesity	3.33e-05	0.000302	CcSEcCtD
Gabapentin—Renal failure—Topiramate—obesity	3.33e-05	0.000301	CcSEcCtD
Gabapentin—Pain—Sibutramine—obesity	3.32e-05	0.000301	CcSEcCtD
Gabapentin—Constipation—Sibutramine—obesity	3.32e-05	0.000301	CcSEcCtD
Gabapentin—Nervous system disorder—Bupropion—obesity	3.32e-05	0.000301	CcSEcCtD
Gabapentin—Neuropathy peripheral—Topiramate—obesity	3.32e-05	0.0003	CcSEcCtD
Gabapentin—Thrombocytopenia—Bupropion—obesity	3.32e-05	0.0003	CcSEcCtD
Gabapentin—Feeling abnormal—Orlistat—obesity	3.31e-05	0.0003	CcSEcCtD
Gabapentin—Tachycardia—Bupropion—obesity	3.31e-05	0.000299	CcSEcCtD
Gabapentin—Stomatitis—Topiramate—obesity	3.3e-05	0.000299	CcSEcCtD
Gabapentin—Skin disorder—Bupropion—obesity	3.29e-05	0.000298	CcSEcCtD
Gabapentin—Conjunctivitis—Topiramate—obesity	3.29e-05	0.000298	CcSEcCtD
Gabapentin—Urinary tract infection—Topiramate—obesity	3.29e-05	0.000298	CcSEcCtD
Gabapentin—Gastrointestinal pain—Orlistat—obesity	3.28e-05	0.000297	CcSEcCtD
Gabapentin—Hyperhidrosis—Bupropion—obesity	3.27e-05	0.000297	CcSEcCtD
Gabapentin—Anorexia—Bupropion—obesity	3.23e-05	0.000292	CcSEcCtD
Gabapentin—Haematuria—Topiramate—obesity	3.23e-05	0.000292	CcSEcCtD
Gabapentin—Feeling abnormal—Sibutramine—obesity	3.2e-05	0.00029	CcSEcCtD
Gabapentin—Epistaxis—Topiramate—obesity	3.19e-05	0.000289	CcSEcCtD
Gabapentin—Urticaria—Orlistat—obesity	3.19e-05	0.000289	CcSEcCtD
Gabapentin—Gastrointestinal pain—Sibutramine—obesity	3.18e-05	0.000288	CcSEcCtD
Gabapentin—Sinusitis—Topiramate—obesity	3.17e-05	0.000287	CcSEcCtD
Gabapentin—Abdominal pain—Orlistat—obesity	3.17e-05	0.000287	CcSEcCtD
Gabapentin—Body temperature increased—Orlistat—obesity	3.17e-05	0.000287	CcSEcCtD
Gabapentin—Hypotension—Bupropion—obesity	3.17e-05	0.000287	CcSEcCtD
Gabapentin—Bradycardia—Topiramate—obesity	3.09e-05	0.00028	CcSEcCtD
Gabapentin—Urticaria—Sibutramine—obesity	3.09e-05	0.00028	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Bupropion—obesity	3.09e-05	0.000279	CcSEcCtD
Gabapentin—Body temperature increased—Sibutramine—obesity	3.07e-05	0.000278	CcSEcCtD
Gabapentin—Abdominal pain—Sibutramine—obesity	3.07e-05	0.000278	CcSEcCtD
Gabapentin—Insomnia—Bupropion—obesity	3.06e-05	0.000277	CcSEcCtD
Gabapentin—Rhinitis—Topiramate—obesity	3.05e-05	0.000276	CcSEcCtD
Gabapentin—Paraesthesia—Bupropion—obesity	3.04e-05	0.000275	CcSEcCtD
Gabapentin—Haemorrhage—Topiramate—obesity	3.04e-05	0.000275	CcSEcCtD
Gabapentin—Hepatitis—Topiramate—obesity	3.04e-05	0.000275	CcSEcCtD
Gabapentin—Hypoaesthesia—Topiramate—obesity	3.02e-05	0.000274	CcSEcCtD
Gabapentin—Hallucination—Topiramate—obesity	3.02e-05	0.000274	CcSEcCtD
Gabapentin—Dyspnoea—Bupropion—obesity	3.02e-05	0.000273	CcSEcCtD
Gabapentin—Pharyngitis—Topiramate—obesity	3.01e-05	0.000273	CcSEcCtD
Gabapentin—Somnolence—Bupropion—obesity	3.01e-05	0.000273	CcSEcCtD
Gabapentin—Urinary tract disorder—Topiramate—obesity	3e-05	0.000272	CcSEcCtD
Gabapentin—Oedema peripheral—Topiramate—obesity	2.99e-05	0.000271	CcSEcCtD
Gabapentin—Connective tissue disorder—Topiramate—obesity	2.99e-05	0.00027	CcSEcCtD
Gabapentin—Dyspepsia—Bupropion—obesity	2.98e-05	0.00027	CcSEcCtD
Gabapentin—Urethral disorder—Topiramate—obesity	2.98e-05	0.00027	CcSEcCtD
Gabapentin—Hypersensitivity—Orlistat—obesity	2.96e-05	0.000268	CcSEcCtD
Gabapentin—Decreased appetite—Bupropion—obesity	2.94e-05	0.000267	CcSEcCtD
Gabapentin—Visual impairment—Topiramate—obesity	2.93e-05	0.000265	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Bupropion—obesity	2.92e-05	0.000265	CcSEcCtD
Gabapentin—Fatigue—Bupropion—obesity	2.92e-05	0.000264	CcSEcCtD
Gabapentin—Pain—Bupropion—obesity	2.9e-05	0.000262	CcSEcCtD
Gabapentin—Constipation—Bupropion—obesity	2.9e-05	0.000262	CcSEcCtD
Gabapentin—Asthenia—Orlistat—obesity	2.88e-05	0.000261	CcSEcCtD
Gabapentin—Erythema multiforme—Topiramate—obesity	2.87e-05	0.00026	CcSEcCtD
Gabapentin—Hypersensitivity—Sibutramine—obesity	2.86e-05	0.000259	CcSEcCtD
Gabapentin—Pruritus—Orlistat—obesity	2.84e-05	0.000257	CcSEcCtD
Gabapentin—Eye disorder—Topiramate—obesity	2.84e-05	0.000257	CcSEcCtD
Gabapentin—Tinnitus—Topiramate—obesity	2.83e-05	0.000256	CcSEcCtD
Gabapentin—Cardiac disorder—Topiramate—obesity	2.82e-05	0.000255	CcSEcCtD
Gabapentin—Feeling abnormal—Bupropion—obesity	2.79e-05	0.000253	CcSEcCtD
Gabapentin—Asthenia—Sibutramine—obesity	2.79e-05	0.000252	CcSEcCtD
Gabapentin—Gastrointestinal pain—Bupropion—obesity	2.77e-05	0.000251	CcSEcCtD
Gabapentin—Pruritus—Sibutramine—obesity	2.75e-05	0.000249	CcSEcCtD
Gabapentin—Diarrhoea—Orlistat—obesity	2.75e-05	0.000249	CcSEcCtD
Gabapentin—Immune system disorder—Topiramate—obesity	2.74e-05	0.000248	CcSEcCtD
Gabapentin—Mediastinal disorder—Topiramate—obesity	2.74e-05	0.000248	CcSEcCtD
Gabapentin—Chills—Topiramate—obesity	2.73e-05	0.000247	CcSEcCtD
Gabapentin—Urticaria—Bupropion—obesity	2.69e-05	0.000244	CcSEcCtD
Gabapentin—Alopecia—Topiramate—obesity	2.68e-05	0.000243	CcSEcCtD
Gabapentin—Body temperature increased—Bupropion—obesity	2.68e-05	0.000242	CcSEcCtD
Gabapentin—Abdominal pain—Bupropion—obesity	2.68e-05	0.000242	CcSEcCtD
Gabapentin—Mental disorder—Topiramate—obesity	2.66e-05	0.000241	CcSEcCtD
Gabapentin—Diarrhoea—Sibutramine—obesity	2.66e-05	0.000241	CcSEcCtD
Gabapentin—Dizziness—Orlistat—obesity	2.65e-05	0.00024	CcSEcCtD
Gabapentin—Erythema—Topiramate—obesity	2.64e-05	0.000239	CcSEcCtD
Gabapentin—Malnutrition—Topiramate—obesity	2.64e-05	0.000239	CcSEcCtD
Gabapentin—Flatulence—Topiramate—obesity	2.61e-05	0.000236	CcSEcCtD
Gabapentin—Tension—Topiramate—obesity	2.59e-05	0.000235	CcSEcCtD
Gabapentin—Dysgeusia—Topiramate—obesity	2.59e-05	0.000234	CcSEcCtD
Gabapentin—Dizziness—Sibutramine—obesity	2.57e-05	0.000233	CcSEcCtD
Gabapentin—Nervousness—Topiramate—obesity	2.57e-05	0.000233	CcSEcCtD
Gabapentin—Back pain—Topiramate—obesity	2.56e-05	0.000232	CcSEcCtD
Gabapentin—Vomiting—Orlistat—obesity	2.55e-05	0.000231	CcSEcCtD
Gabapentin—Muscle spasms—Topiramate—obesity	2.54e-05	0.00023	CcSEcCtD
Gabapentin—Rash—Orlistat—obesity	2.53e-05	0.000229	CcSEcCtD
Gabapentin—Dermatitis—Orlistat—obesity	2.53e-05	0.000229	CcSEcCtD
Gabapentin—Headache—Orlistat—obesity	2.52e-05	0.000228	CcSEcCtD
Gabapentin—Hypersensitivity—Bupropion—obesity	2.5e-05	0.000226	CcSEcCtD
Gabapentin—Vision blurred—Topiramate—obesity	2.49e-05	0.000226	CcSEcCtD
Gabapentin—Tremor—Topiramate—obesity	2.48e-05	0.000224	CcSEcCtD
Gabapentin—Vomiting—Sibutramine—obesity	2.47e-05	0.000224	CcSEcCtD
Gabapentin—Ill-defined disorder—Topiramate—obesity	2.45e-05	0.000222	CcSEcCtD
Gabapentin—Rash—Sibutramine—obesity	2.45e-05	0.000222	CcSEcCtD
Gabapentin—Dermatitis—Sibutramine—obesity	2.45e-05	0.000222	CcSEcCtD
Gabapentin—Anaemia—Topiramate—obesity	2.44e-05	0.000221	CcSEcCtD
Gabapentin—Headache—Sibutramine—obesity	2.43e-05	0.00022	CcSEcCtD
Gabapentin—Asthenia—Bupropion—obesity	2.43e-05	0.00022	CcSEcCtD
Gabapentin—Agitation—Topiramate—obesity	2.43e-05	0.00022	CcSEcCtD
Gabapentin—Pruritus—Bupropion—obesity	2.4e-05	0.000217	CcSEcCtD
Gabapentin—Nausea—Orlistat—obesity	2.38e-05	0.000216	CcSEcCtD
Gabapentin—Malaise—Topiramate—obesity	2.38e-05	0.000216	CcSEcCtD
Gabapentin—Vertigo—Topiramate—obesity	2.38e-05	0.000215	CcSEcCtD
Gabapentin—Syncope—Topiramate—obesity	2.37e-05	0.000215	CcSEcCtD
Gabapentin—Leukopenia—Topiramate—obesity	2.37e-05	0.000214	CcSEcCtD
Gabapentin—Palpitations—Topiramate—obesity	2.34e-05	0.000212	CcSEcCtD
Gabapentin—Loss of consciousness—Topiramate—obesity	2.32e-05	0.00021	CcSEcCtD
Gabapentin—Diarrhoea—Bupropion—obesity	2.32e-05	0.00021	CcSEcCtD
Gabapentin—Nausea—Sibutramine—obesity	2.31e-05	0.000209	CcSEcCtD
Gabapentin—Cough—Topiramate—obesity	2.31e-05	0.000209	CcSEcCtD
Gabapentin—Convulsion—Topiramate—obesity	2.29e-05	0.000207	CcSEcCtD
Gabapentin—Hypertension—Topiramate—obesity	2.28e-05	0.000207	CcSEcCtD
Gabapentin—BCAT1—Metabolism—HMOX1—obesity	2.27e-05	0.000524	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IAPP—obesity	2.26e-05	0.000523	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—MAPK8—obesity	2.25e-05	0.000521	CbGpPWpGaD
Gabapentin—Myalgia—Topiramate—obesity	2.25e-05	0.000204	CcSEcCtD
Gabapentin—Chest pain—Topiramate—obesity	2.25e-05	0.000204	CcSEcCtD
Gabapentin—Arthralgia—Topiramate—obesity	2.25e-05	0.000204	CcSEcCtD
Gabapentin—Anxiety—Topiramate—obesity	2.24e-05	0.000203	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—APLN—obesity	2.24e-05	0.000518	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PYY—obesity	2.24e-05	0.000518	CbGpPWpGaD
Gabapentin—Dizziness—Bupropion—obesity	2.24e-05	0.000203	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	2.24e-05	0.000202	CcSEcCtD
Gabapentin—Discomfort—Topiramate—obesity	2.22e-05	0.000201	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GNAS—obesity	2.22e-05	0.000512	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—HTR2A—obesity	2.22e-05	0.000512	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—C3—obesity	2.21e-05	0.000511	CbGpPWpGaD
Gabapentin—Dry mouth—Topiramate—obesity	2.2e-05	0.000199	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PRKAR2B—obesity	2.2e-05	0.000508	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CRH—obesity	2.2e-05	0.000507	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR1B—obesity	2.2e-05	0.000507	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PRKAR2B—obesity	2.19e-05	0.000505	CbGpPWpGaD
Gabapentin—Confusional state—Topiramate—obesity	2.18e-05	0.000197	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—DCN—obesity	2.17e-05	0.000502	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOB—obesity	2.17e-05	0.000502	CbGpPWpGaD
Gabapentin—Oedema—Topiramate—obesity	2.16e-05	0.000195	CcSEcCtD
Gabapentin—Vomiting—Bupropion—obesity	2.15e-05	0.000195	CcSEcCtD
Gabapentin—Infection—Topiramate—obesity	2.14e-05	0.000194	CcSEcCtD
Gabapentin—Rash—Bupropion—obesity	2.14e-05	0.000193	CcSEcCtD
Gabapentin—Dermatitis—Bupropion—obesity	2.13e-05	0.000193	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PNLIP—obesity	2.13e-05	0.000491	CbGpPWpGaD
Gabapentin—Shock—Topiramate—obesity	2.12e-05	0.000192	CcSEcCtD
Gabapentin—Headache—Bupropion—obesity	2.12e-05	0.000192	CcSEcCtD
Gabapentin—Nervous system disorder—Topiramate—obesity	2.12e-05	0.000192	CcSEcCtD
Gabapentin—Thrombocytopenia—Topiramate—obesity	2.11e-05	0.000191	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CPT1A—obesity	2.11e-05	0.000488	CbGpPWpGaD
Gabapentin—Tachycardia—Topiramate—obesity	2.11e-05	0.000191	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—AGT—obesity	2.1e-05	0.000486	CbGpPWpGaD
Gabapentin—Skin disorder—Topiramate—obesity	2.1e-05	0.00019	CcSEcCtD
Gabapentin—Hyperhidrosis—Topiramate—obesity	2.09e-05	0.000189	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—NPS—obesity	2.08e-05	0.000481	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SDC3—obesity	2.08e-05	0.00048	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPL—obesity	2.07e-05	0.000479	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAMPT—obesity	2.07e-05	0.000479	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NPY—obesity	2.07e-05	0.000478	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LIPC—obesity	2.06e-05	0.000476	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCK—obesity	2.06e-05	0.000476	CbGpPWpGaD
Gabapentin—Anorexia—Topiramate—obesity	2.06e-05	0.000186	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IAPP—obesity	2.05e-05	0.000475	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOC3—obesity	2.05e-05	0.000473	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2C—obesity	2.04e-05	0.000472	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—DRD1—obesity	2.04e-05	0.000472	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PMCH—obesity	2.03e-05	0.000469	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPY5R—obesity	2.03e-05	0.000469	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NMU—obesity	2.03e-05	0.000469	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HCRT—obesity	2.03e-05	0.000469	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPX1—obesity	2.02e-05	0.000467	CbGpPWpGaD
Gabapentin—Hypotension—Topiramate—obesity	2.02e-05	0.000183	CcSEcCtD
Gabapentin—Nausea—Bupropion—obesity	2.01e-05	0.000182	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—HTR1B—obesity	1.99e-05	0.000461	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CRH—obesity	1.99e-05	0.000461	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CETP—obesity	1.99e-05	0.000459	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB1—obesity	1.98e-05	0.000457	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD36—obesity	1.97e-05	0.000455	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Topiramate—obesity	1.97e-05	0.000178	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SDC1—obesity	1.96e-05	0.000454	CbGpPWpGaD
Gabapentin—Insomnia—Topiramate—obesity	1.95e-05	0.000177	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MC3R—obesity	1.95e-05	0.000449	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPY1R—obesity	1.95e-05	0.000449	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPY2R—obesity	1.95e-05	0.000449	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MC4R—obesity	1.95e-05	0.000449	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—F2—obesity	1.94e-05	0.000449	CbGpPWpGaD
Gabapentin—Paraesthesia—Topiramate—obesity	1.94e-05	0.000175	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GHRL—obesity	1.94e-05	0.000447	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKR1C3—obesity	1.93e-05	0.000446	CbGpPWpGaD
Gabapentin—Dyspnoea—Topiramate—obesity	1.92e-05	0.000174	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—DRD4—obesity	1.92e-05	0.000444	CbGpPWpGaD
Gabapentin—Somnolence—Topiramate—obesity	1.92e-05	0.000174	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PPY—obesity	1.91e-05	0.000441	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SCARB1—obesity	1.9e-05	0.000439	CbGpPWpGaD
Gabapentin—Dyspepsia—Topiramate—obesity	1.9e-05	0.000172	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—NPS—obesity	1.89e-05	0.000437	CbGpPWpGaD
Gabapentin—Decreased appetite—Topiramate—obesity	1.88e-05	0.00017	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HDAC8—obesity	1.87e-05	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCH—obesity	1.87e-05	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GIP—obesity	1.87e-05	0.000433	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—obesity	1.87e-05	0.000431	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Topiramate—obesity	1.86e-05	0.000169	CcSEcCtD
Gabapentin—Fatigue—Topiramate—obesity	1.86e-05	0.000168	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—DRD1—obesity	1.85e-05	0.000428	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HTR2C—obesity	1.85e-05	0.000428	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SREBF1—obesity	1.85e-05	0.000427	CbGpPWpGaD
Gabapentin—Constipation—Topiramate—obesity	1.85e-05	0.000167	CcSEcCtD
Gabapentin—Pain—Topiramate—obesity	1.85e-05	0.000167	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CNR1—obesity	1.83e-05	0.000424	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARA—obesity	1.83e-05	0.000423	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB1—obesity	1.8e-05	0.000415	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT2—obesity	1.8e-05	0.000415	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—DRD2—obesity	1.79e-05	0.000413	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEPR—obesity	1.78e-05	0.000411	CbGpPWpGaD
Gabapentin—Feeling abnormal—Topiramate—obesity	1.78e-05	0.000161	CcSEcCtD
Gabapentin—BCAT1—Metabolism—AGT—obesity	1.77e-05	0.00041	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GCG—obesity	1.77e-05	0.000409	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—POMC—obesity	1.77e-05	0.000409	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Topiramate—obesity	1.76e-05	0.00016	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GHRL—obesity	1.76e-05	0.000406	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FASN—obesity	1.76e-05	0.000406	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BCHE—obesity	1.75e-05	0.000404	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—DRD4—obesity	1.74e-05	0.000403	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—obesity	1.74e-05	0.000401	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—obesity	1.73e-05	0.0004	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAV1—obesity	1.72e-05	0.000398	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA1—obesity	1.72e-05	0.000397	CbGpPWpGaD
Gabapentin—Urticaria—Topiramate—obesity	1.71e-05	0.000155	CcSEcCtD
Gabapentin—Abdominal pain—Topiramate—obesity	1.71e-05	0.000154	CcSEcCtD
Gabapentin—Body temperature increased—Topiramate—obesity	1.71e-05	0.000154	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP2E1—obesity	1.69e-05	0.00039	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NQO1—obesity	1.67e-05	0.000386	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR1—obesity	1.67e-05	0.000385	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—DRD2—obesity	1.62e-05	0.000375	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GCG—obesity	1.61e-05	0.000371	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB2—obesity	1.6e-05	0.00037	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A4—obesity	1.6e-05	0.00037	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCG—obesity	1.6e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB3—obesity	1.59e-05	0.000368	CbGpPWpGaD
Gabapentin—Hypersensitivity—Topiramate—obesity	1.59e-05	0.000144	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYCS—obesity	1.58e-05	0.000365	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—obesity	1.57e-05	0.000362	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GAL—obesity	1.56e-05	0.000359	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT1—obesity	1.55e-05	0.000358	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GGT1—obesity	1.55e-05	0.000358	CbGpPWpGaD
Gabapentin—Asthenia—Topiramate—obesity	1.55e-05	0.00014	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—C5AR1—obesity	1.54e-05	0.000355	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA1—obesity	1.53e-05	0.000353	CbGpPWpGaD
Gabapentin—Pruritus—Topiramate—obesity	1.53e-05	0.000138	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GNB3—obesity	1.53e-05	0.000353	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—obesity	1.51e-05	0.00035	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—STK11—obesity	1.51e-05	0.000348	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP19A1—obesity	1.51e-05	0.000348	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—POMC—obesity	1.49e-05	0.000345	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNAS—obesity	1.49e-05	0.000343	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—obesity	1.48e-05	0.000343	CbGpPWpGaD
Gabapentin—Diarrhoea—Topiramate—obesity	1.48e-05	0.000134	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—ADRB2—obesity	1.46e-05	0.000336	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—obesity	1.44e-05	0.000333	CbGpPWpGaD
Gabapentin—Dizziness—Topiramate—obesity	1.43e-05	0.000129	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CCL5—obesity	1.42e-05	0.000328	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCK—obesity	1.41e-05	0.000325	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKG1—obesity	1.41e-05	0.000325	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—COMT—obesity	1.4e-05	0.000323	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNB3—obesity	1.39e-05	0.00032	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNB3—obesity	1.38e-05	0.000319	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARGC1A—obesity	1.38e-05	0.000319	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—obesity	1.38e-05	0.000319	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—obesity	1.37e-05	0.000317	CbGpPWpGaD
Gabapentin—Vomiting—Topiramate—obesity	1.37e-05	0.000124	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—RBP4—obesity	1.37e-05	0.000317	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GLP1R—obesity	1.37e-05	0.000317	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—obesity	1.36e-05	0.000314	CbGpPWpGaD
Gabapentin—Rash—Topiramate—obesity	1.36e-05	0.000123	CcSEcCtD
Gabapentin—Dermatitis—Topiramate—obesity	1.36e-05	0.000123	CcSEcCtD
Gabapentin—Headache—Topiramate—obesity	1.35e-05	0.000122	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GNAS—obesity	1.35e-05	0.000312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCKAR—obesity	1.35e-05	0.000311	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRH3—obesity	1.35e-05	0.000311	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNAS—obesity	1.34e-05	0.00031	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOB—obesity	1.32e-05	0.000304	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3R1—obesity	1.3e-05	0.000301	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—obesity	1.3e-05	0.000301	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKAR2B—obesity	1.3e-05	0.0003	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL5—obesity	1.29e-05	0.000298	CbGpPWpGaD
Gabapentin—Nausea—Topiramate—obesity	1.28e-05	0.000116	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCD—obesity	1.28e-05	0.000296	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPL—obesity	1.26e-05	0.00029	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCF2—obesity	1.25e-05	0.00029	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2A—obesity	1.25e-05	0.000289	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—C3—obesity	1.25e-05	0.000289	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPX1—obesity	1.23e-05	0.000283	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPY—obesity	1.22e-05	0.000282	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IAPP—obesity	1.21e-05	0.00028	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOC3—obesity	1.21e-05	0.00028	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—obesity	1.2e-05	0.000278	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CD36—obesity	1.19e-05	0.000276	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—obesity	1.19e-05	0.000275	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGT—obesity	1.19e-05	0.000275	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR1B—obesity	1.18e-05	0.000272	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CRH—obesity	1.18e-05	0.000272	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SDC1—obesity	1.17e-05	0.000269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCD—obesity	1.16e-05	0.000269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKR1C3—obesity	1.15e-05	0.000265	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HTR2A—obesity	1.14e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—C3—obesity	1.14e-05	0.000262	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—obesity	1.13e-05	0.000261	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPS—obesity	1.12e-05	0.000258	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARA—obesity	1.11e-05	0.000256	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2—obesity	1.1e-05	0.000254	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCB—obesity	1.1e-05	0.000254	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2C—obesity	1.1e-05	0.000253	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DRD1—obesity	1.1e-05	0.000253	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGT—obesity	1.08e-05	0.000249	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AGT—obesity	1.07e-05	0.000248	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NTRK2—obesity	1.07e-05	0.000246	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB1—obesity	1.06e-05	0.000245	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—obesity	1.05e-05	0.000243	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—obesity	1.05e-05	0.000243	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAV1—obesity	1.04e-05	0.000241	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA1—obesity	1.04e-05	0.00024	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PARP1—obesity	1.04e-05	0.00024	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHRL—obesity	1.04e-05	0.00024	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DRD4—obesity	1.03e-05	0.000238	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—obesity	1e-05	0.000231	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2—obesity	9.97e-06	0.00023	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCB—obesity	9.97e-06	0.00023	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR1—obesity	9.84e-06	0.000227	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TCF7L2—obesity	9.66e-06	0.000223	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT2—obesity	9.62e-06	0.000222	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DRD2—obesity	9.6e-06	0.000222	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—obesity	9.55e-06	0.000221	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—obesity	9.5e-06	0.00022	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTPN1—obesity	9.5e-06	0.000219	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GCG—obesity	9.5e-06	0.000219	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—obesity	9.24e-06	0.000213	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—obesity	9.17e-06	0.000212	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—POMC—obesity	9.09e-06	0.00021	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRL—obesity	9.06e-06	0.000209	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—POMC—obesity	9.05e-06	0.000209	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—obesity	9e-06	0.000208	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STK11—obesity	8.93e-06	0.000206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—obesity	8.89e-06	0.000205	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLG—obesity	8.83e-06	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RHOA—obesity	8.82e-06	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT2—obesity	8.73e-06	0.000202	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3R1—obesity	8.73e-06	0.000202	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FOXO3—obesity	8.62e-06	0.000199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB2—obesity	8.6e-06	0.000199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOCS1—obesity	8.47e-06	0.000196	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—obesity	8.39e-06	0.000194	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOCS3—obesity	8.36e-06	0.000193	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—obesity	8.35e-06	0.000193	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—obesity	8.25e-06	0.000191	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNB3—obesity	8.19e-06	0.000189	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—TYK2—obesity	8.07e-06	0.000186	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—obesity	8.05e-06	0.000186	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—obesity	8.04e-06	0.000186	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RHOA—obesity	8.01e-06	0.000185	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNAS—obesity	7.97e-06	0.000184	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3R1—obesity	7.92e-06	0.000183	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3R1—obesity	7.89e-06	0.000182	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—obesity	7.89e-06	0.000182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOB—obesity	7.81e-06	0.00018	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL5—obesity	7.62e-06	0.000176	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPL—obesity	7.45e-06	0.000172	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FOXO1—obesity	7.4e-06	0.000171	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RPS6KB1—obesity	7.39e-06	0.000171	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—obesity	7.33e-06	0.000169	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—obesity	7.31e-06	0.000169	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—obesity	7.28e-06	0.000168	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—obesity	7.21e-06	0.000167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCD—obesity	6.87e-06	0.000159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2A—obesity	6.72e-06	0.000155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—C3—obesity	6.71e-06	0.000155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS2—obesity	6.38e-06	0.000147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGT—obesity	6.38e-06	0.000147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—obesity	6.25e-06	0.000144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—obesity	6.25e-06	0.000144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—obesity	6.19e-06	0.000143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA1—obesity	6.18e-06	0.000143	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—obesity	5.99e-06	0.000138	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—obesity	5.97e-06	0.000138	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2—obesity	5.89e-06	0.000136	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCB—obesity	5.89e-06	0.000136	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BAD—obesity	5.82e-06	0.000134	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—obesity	5.64e-06	0.00013	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS1—obesity	5.57e-06	0.000129	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—obesity	5.37e-06	0.000124	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—obesity	5.34e-06	0.000123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—obesity	5.25e-06	0.000121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—obesity	5.16e-06	0.000119	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT2—obesity	5.16e-06	0.000119	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—obesity	4.96e-06	0.000115	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—obesity	4.91e-06	0.000113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—obesity	4.9e-06	0.000113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TYK2—obesity	4.77e-06	0.00011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RHOA—obesity	4.73e-06	0.000109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—obesity	4.68e-06	0.000108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3R1—obesity	4.68e-06	0.000108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—obesity	4.46e-06	0.000103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—obesity	4.44e-06	0.000103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—obesity	4.32e-06	9.98e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTOR—obesity	4.32e-06	9.98e-05	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—obesity	4.01e-06	9.27e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—obesity	3.95e-06	9.12e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—obesity	3.76e-06	8.68e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK8—obesity	3.65e-06	8.44e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—obesity	3.64e-06	8.41e-05	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—obesity	3.63e-06	8.38e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—obesity	3.34e-06	7.71e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—obesity	3.1e-06	7.17e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—obesity	3.1e-06	7.15e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—obesity	2.63e-06	6.08e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—obesity	2.33e-06	5.39e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—obesity	2.15e-06	4.97e-05	CbGpPWpGaD
